Adocia SA
EPA:ADOC.PA
5.7 (EUR) • At close September 18, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Adocia SA |
Symbool | ADOC.PA |
Munteenheid | EUR |
Prijs | 5.7 |
Beurswaarde | 85,733,432 |
Dividendpercentage | 0% |
52-weken bereik | 5.11 - 12.66 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Olivier Soula M.B.A., Ph.D. |
Website | https://www.adocia.com |
An error occurred while fetching data.
Over Adocia SA
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform is designed and developed to optimize the performance of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)